Topical Antibiotics Market Trends

Report ID: GMI8570
   |
Published Date: March 2024
 | 
Report Format: PDF

Download Free PDF

Topical Antibiotics Market Trends

  • The increasing microbial resistance to systemic antibiotics has enhanced the significance of topical antibiotics. As conventional antibiotic treatments lose effectiveness against resistant microbes, topical antibiotics have emerged as a valuable alternative for treating localized infections.
     
  • For instance, RMIT scientists developed Priscilicidin, a novel antibiotic with the unique ability to be rapidly re-engineered to evade resistance from harmful superbugs. This antibiotic, characterized by its small amino acid building blocks, offered adaptability to combat various forms of antimicrobial resistance. Thus, the growing innovative research reflects the increasing efforts to address antimicrobial resistance broadening antibiotic efficacy, thereby exploring opportunities for topical antibiotics in the market.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are the leading topical antibiotics industry players?
Some of the prominent topical antibiotic firms are Almirall S.A., Bausch Health Companies Inc., Bayer AG, GlaxoSmithKline plc, Johnson & Johnson Consumer Inc., and Lupin, among others.
What is the size of the topical antibiotics market?
Why is the use of topical tetracyclines growing?
How much is the North America topical antibiotics market worth?
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2023

    Companies covered: 15

    Tables & Figures: 292

    Countries covered: 19

    Pages: 160

    Download Free PDF

    Top